These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7767515)

  • 41. Platelet-activating factor impairs mucociliary transport and increases plasma leukotriene B4 in man.
    Nieminen MM; Moilanen EK; Nyholm J-E ; Koskinen MO; Karvonen JI; Metsä-Ketelä TJ; Vapaatalo H
    Eur Respir J; 1991 May; 4(5):551-60. PubMed ID: 1657632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen.
    Kuitert LM; Hui KP; Uthayarkumar S; Burke W; Newland AC; Uden S; Barnes NC
    Am Rev Respir Dis; 1993 Jan; 147(1):82-6. PubMed ID: 8420437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tidal volume dependency of gas exchange in bronchoconstricted pig lungs.
    Kleinsasser A; Olfert IM; Loeckinger A; Prisk GK; Hopkins SR; Wagner PD
    J Appl Physiol (1985); 2007 Jul; 103(1):148-55. PubMed ID: 17395763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary gas exchange and sputum cellular responses to inhaled leukotriene D(4) in asthma.
    Echazarreta AL; Dahlén B; García G; Agustí C; Barberà JA; Roca J; Dahlén SE; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 2001 Jul; 164(2):202-6. PubMed ID: 11463588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man.
    Cuss FM; Dixon CM; Barnes PJ
    Lancet; 1986 Jul; 2(8500):189-92. PubMed ID: 2873440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salbutamol inhibits metabisulphite-induced bronchoconstriction.
    Iredale MJ; Dixon CM; Ind PW
    Br J Clin Pharmacol; 1991 Nov; 32(5):637-8. PubMed ID: 1954080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man.
    Chung KF; Minette P; McCusker M; Barnes PJ
    J Allergy Clin Immunol; 1988 Jun; 81(6):1192-8. PubMed ID: 3288683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man.
    Spencer DA; Green SE; Evans JM; Piper PJ; Costello JF
    Clin Exp Allergy; 1990 Sep; 20(5):525-32. PubMed ID: 2253083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pressure effects and uptake of platelet-activating factor in isolated rat lung.
    Lichey J; Friedrich T; Franke J; Nigam S; Priesnitz M; Oeff K
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Oct; 57(4):1039-44. PubMed ID: 6501025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of inhaled platelet activating factor on bronchial responsiveness in patients with symptomatic and asymptomatic pulmonary embolism.
    Ruiz J; Monreal M; Sala H; Roncalés J; Fiz JA; Monsó E; Morera J
    Chest; 1992 Sep; 102(3):819-23. PubMed ID: 1516409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of platelet activating factor on nasal hypersensitivity.
    Andersson M; Pipkorn U
    Eur J Clin Pharmacol; 1988; 35(3):231-5. PubMed ID: 3181276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhalation of platelet-activating factor increases respiratory resistance in rats: determination by means of an astograph under nonanesthetized conditions.
    Kosugi T; Saitoh S; Tamaki N; Hanashiro K; Nakahodo K; Nakamura M
    Laryngoscope; 1993 Apr; 103(4 Pt 1):428-30. PubMed ID: 8459752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibronectin levels in plasma after platelet-activating factor inhalation.
    Nabe M; Miyagawa H; Hopp RJ; Agrawal DK; Bewtra AK; Townley RG
    Int Arch Allergy Appl Immunol; 1990; 91(2):113-7. PubMed ID: 2341190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the cholinergic pathway in mediating platelet-activating factor-induced pulmonary dysfunctions in unsedated calves.
    Van de Weerdt ML; Husson C; Lekeux P
    Zentralbl Veterinarmed A; 1999 Mar; 46(2):103-13. PubMed ID: 10216447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PAF antagonists in asthma.
    Lancet; 1989 Mar; 1(8638):592-3. PubMed ID: 2564116
    [No Abstract]   [Full Text] [Related]  

  • 56. Salbutamol but not ipratropium abolishes leukotriene D4-induced gas exchange abnormalities in asthma.
    Dahlén B; Gómez FP; Casas A; Howarth PH; Dahlén SE; Rodriguez-Roisin R
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1375-83. PubMed ID: 22457014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet activating factor as a mediator and therapeutic approach in bronchial asthma.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Inflammation; 2008 Apr; 31(2):112-20. PubMed ID: 18193345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salbutamol inhibits pulmonary effects of platelet activating factor in man.
    Roca J; Félez MA; Chung KF; Barberà JA; Rotger M; Santos C; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1740-4. PubMed ID: 7767515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation.
    Díaz O; Barberà JA; Marrades R; Chung KF; Roca J; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1997 Jul; 156(1):17-22. PubMed ID: 9230720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhaled platelet-activating factor worsens gas exchange in mild asthma.
    Félez MA; Roca J; Barberà JA; Santos C; Rotger M; Chung KF; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1994 Aug; 150(2):369-73. PubMed ID: 8049817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.